You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
水羊股份(300740.SZ):與江南大學合作開發的四氫嘧啶(依克多因)菌株已可實現量產
格隆匯 05-10 07:39

格隆匯5月10日丨水羊股份(300740.SZ)在投資者互動平台表示,在合成生物領域,公司較早與江南大學陳堅院士團隊合作,並於2022年聘請陳堅院士為首席科學家,已取得11項專利技術;其中,江南大學轉讓利用合成生物學進行小分子玻尿酸生產的相關專利6項,自主研發獲得原料製備、檢測及應用專利5項,並將相關技術應用於御泥坊微800、微400玻尿酸次拋精華等產品中。此外,與江南大學合作開發的四氫嘧啶(依克多因)菌株已可實現量產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account